More News! 12 Jun 2019 Evotec to Reduce the Burden of Tuberculosis Treatment with €21M Grant The Bill and Melinda Gates Foundation has granted the German biotech Evotec €21M ($23.8M) to discover drug combinations that can reduce the duration of tuberculosis treatment, which normally takes over six months. Evotec will use the money to test different drug combinations for tuberculosis in the preclinical stage. The partnership will last for five years, […] June 12, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 11 Jun 2019 Janssen and Genmab Team Up Again for Another Potential Cancer Blockbuster Janssen and the Danish biotech Genmab will collaborate to develop a new antibody that could outperform their blockbuster cancer drug Darzalex in certain types of blood cancer. Genmab will develop the antibody treatment until it completes clinical proof-of-concept studies in the blood cancers multiple myeloma and diffuse large B-cell lymphoma. At that point, Janssen will […] June 11, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 11 Jun 2019 Gamma Delta T Cells: A New Hope Against Cancer A new wave of therapies based on a unique type of immune cells, called gamma delta T cells, has the potential to treat cancer with stronger responses and fewer side effects. Immunotherapies based on T cells are becoming a huge trend in the treatment of cancer, especially CAR-T cells. These genetically-modified T cells have shown […] June 11, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Jun 2019 The 10 Biotech Companies in London to Keep an Eye on in 2019 Which biotechs will be stealing the show this year? These are some of the most exciting biotech companies in London right now. London is undoubtedly one of the biggest hubs for biotech companies in the U.K. and in Europe. The British capital was the one that received the most life sciences investment in Europe in […] June 10, 2019 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Expert Advice 8 Jun 2019 Why Sticking to Your Beliefs is Important for Biotech Success Galapagos is an undeniable success story. Set up in 1999, it is now one of the largest and most successful biotechs in Europe. A key driving force behind the company is Onno van de Stolpe, its founder and CEO. After doing an internship at Biogen while at university, van de Stolpe knew he wanted to […] June 8, 2019 - 11 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 7 Jun 2019 CRISPR Therapeutics and Vertex Seal Deal Worth up to €890M The US giant Vertex Pharmaceuticals is expanding an existing collaboration with the Swiss company CRISPR Therapeutics, paying up to €890M ($1B) to develop treatments for genetic diseases causing muscle weakness using the gene editing tool CRISPR/Cas9. The deal includes €155M ($175M) paid upfront, and potential future payments based on achieving developmental milestones. In exchange, Vertex […] June 7, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 7 Jun 2019 This Biotech Transplants Cells into the Eye to Personalize Diabetes Treatments Up north in Stockholm, the Swedish company Biocrine aims to personalize diabetes treatments by screening drugs in pancreatic cells that have been transplanted into the eye. Mission: To test new drugs for type 1 and type 2 diabetes on pancreatic cells transplanted into the eye, where the cells can thrive and be easily monitored with […] June 7, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
More News! 6 Jun 2019 Shares Drop 90% as Antibody for Inflammatory Skin Disease Fails Phase II The German company InflaRx has seen its shares on the Nasdaq plummet after announcing that its treatment for an inflammatory skin disease failed to beat the placebo in a phase IIb trial. The trial had enrolled 179 patients with hidradenitis suppurativa, an incurable condition causing painful lumps on the skin. By the 16th week of […] June 6, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 5 Jun 2019 Highlights from European Biotech at ASCO 2019 European biotech companies gathered in Chicago, USA, to share the latest advances in cancer research at the biggest cancer conference of the year, ASCO 2019. This year’s conference has drawn fewer big blockbuster headlines than other years, but there was plenty to see nonetheless. There were results from many different clinical trials by big pharma […] June 5, 2019 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Interview 5 Jun 2019 How Spain is Building a Strong Biotech Ecosystem The biotech sector is rapidly gaining momentum in Spain. At Labiotech Refresh in Barcelona, Raúl Martín-Ruiz, Partner at the venture capital firm Ysios Capital, shared his experience investing in Spain’s biotech industry over the last decade. Ysios Capital made its first investment in 2008. The recipient was a cell therapy company based in Madrid. Then […] June 5, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Opinion 5 Jun 2019 Is Going Public in Europe the Kiss of Death? The key for a European biotech is to find the money where it is. And that’s not in Europe for the moment. Going public is obviously a necessary evil for any biotech company looking to become a self-standing entity taking its drugs to market. Doing so provides the funding, the public forum, and the governance […] June 5, 2019 - 6 minutesmins - By Antoine Papiernik Share WhatsApp Twitter Linkedin Email
News and Trends 4 Jun 2019 Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine The market is in sight for the first potential vaccine for the chikungunya virus, as the company Themis Bioscience will receive up to €18.7M ($21M) in non-dilutive funding to finance the vaccine’s phase III development. The money will cover most of the costs of the phase III trial, which Themis expects to begin later this […] June 4, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email